Novartis AG

NOTA

Company Profile

  • Business description

    Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

  • Contact

    Lichtstrasse 35
    Basel4056
    CHE

    T: +41 613241111

    E: [email protected]

    https://www.novartis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    75,883

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,823.003.70-0.04%
CAC 407,902.2523.790.30%
DAX 4024,456.8192.75-0.38%
Dow JONES (US)44,650.64192.340.43%
FTSE 1008,975.66108.641.23%
HKSE24,380.04351.671.46%
NASDAQ20,630.6619.330.09%
Nikkei 22539,593.8452.52-0.13%
NZX 50 Index12,696.5363.67-0.50%
S&P 5006,280.4617.200.27%
S&P/ASX 2008,584.704.50-0.05%
SSE Composite Index3,538.8029.120.83%

Market Movers